Other OTC Pharmaceuticals (Pharmacies) - Iraq

  • Iraq
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$100.00m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.32%, resulting in a market volume of US$106.80m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.15 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Iraq is experiencing significant development and growth. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences play a crucial role in shaping the Other OTC Pharmaceuticals market in Iraq. Consumers in Iraq are increasingly seeking convenience and accessibility when it comes to purchasing healthcare products. This has led to a rise in demand for over-the-counter medications and other pharmaceutical products that can be easily obtained from local pharmacies without the need for a prescription. Additionally, consumers in Iraq tend to prioritize affordability and value for money, which further drives the demand for OTC pharmaceuticals. Several trends are driving the growth of the Other OTC Pharmaceuticals market in Iraq. Firstly, there has been a significant increase in the number of pharmacies across the country. This expansion of the retail pharmacy sector provides consumers with greater access to OTC medications and healthcare products. Furthermore, the growing urbanization and increasing disposable income levels in Iraq have contributed to the rising demand for OTC pharmaceuticals. As more people move to urban areas and experience improved financial stability, they are more likely to spend on healthcare products to meet their self-care needs. Local special circumstances also impact the development of the Other OTC Pharmaceuticals market in Iraq. The healthcare infrastructure in Iraq has faced challenges due to years of conflict and political instability. As a result, access to healthcare services, including prescription medications, may be limited in certain areas. This has led to an increased reliance on OTC pharmaceuticals as a more accessible and affordable alternative. Additionally, cultural factors also play a role in the preference for OTC medications, as traditional remedies and herbal medicines are often favored by Iraqi consumers. Underlying macroeconomic factors contribute to the growth of the Other OTC Pharmaceuticals market in Iraq. The country's population is growing steadily, which means a larger consumer base for healthcare products. Moreover, the improving economic conditions in Iraq have led to an increase in disposable income levels, allowing consumers to allocate more of their budget towards healthcare and wellness products. Additionally, the government's efforts to improve healthcare services and infrastructure have also positively impacted the OTC Pharmaceuticals market. In conclusion, the Other OTC Pharmaceuticals market in Iraq is experiencing growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. As consumers prioritize convenience, affordability, and accessibility, the demand for OTC pharmaceuticals continues to rise. The expansion of the retail pharmacy sector, improving economic conditions, and the government's focus on healthcare infrastructure all contribute to the positive trajectory of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)